Standard BioTools Inc. (LAB) has a market capitalization of $381.29M and trades at $0.98. The 52-week range is 0.88-1.72.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.9, Earnings Per Share (EPS) of $-0.20, annual revenue of $85.33M.
The stock has a beta of 1.42, operates in the Healthcare sector.